Ensartinib (X-396): what does it add for patients with ALK-rearranged NSCLC

Tianhong Li, Weijie Ma, Eddie C. Tian

Research output: Contribution to journalArticle

3 Scopus citations
Original languageEnglish (US)
Pages (from-to)S4
JournalChinese clinical oncology
Volume8
Issue numberS1
DOIs
StatePublished - Oct 1 2019

ASJC Scopus subject areas

  • Oncology

Cite this